Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

Completed · Phase 4

Conditions studied: Hypertension

In brief

This study will evaluate the efficacy of valsartan/hydrochlorothiazide versus amlodipine and hydrochlorothiazide in patients with Stage 2 hypertension using 24-hr ambulatory blood pressure monitoring (ABPM)

Key facts

Study ID

NCT00425997

Run by

Novartis

People needed

480

Starts

2006-12-01

Expected to finish

2007-10-01

Last updated by the study team

2011-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients 18 years of age or older
• Diagnosed of having hypertension, defined as a mean seated systolic BP ≥160 mmHg (Stage 2 hypertension)

You may not qualify if…

• Symptomatic or severe hypertension
• Patients treated with more than 2 antihypertensive medications
• Clinically known or suspected history of secondary hypertension
• Myocardial infarction, stroke, transient ischemic attack, cardiovascular revascularization/angioplasty in last 6 months
• Diagnosis of heart failure (NYHA Class II-IV)
• Chronic renal or severe hepatic disease

Where it is running

• Sites in USA — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.